SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
07-Feb-18 7:49 PM View: | Soleno Therapeutics Inc (SLNO) | 05-Feb-18 | Grant | 3,962 | $1.73 | $6,839.60 | < 1% 8.47M to 8.47M | 7% |
04-Oct-17 6:04 PM View: | Soleno Therapeutics Inc (SLNO) | 02-Oct-17 | Grant | 13,154 | $0.52 | $6,840.08 | < 1% 7.06M to 7.08M | (28%) |
17-Jul-17 8:55 PM View: | Soleno Therapeutics Inc (SLNO) | 06-Jul-17 | Grant | 11,213 | $0.61 | $6,839.93 | < 1% 7.05M to 7.06M | (36%) |
13-Apr-17 9:26 PM View: | Soleno Therapeutics Inc (SLNO) | 07-Apr-17 | Grant | 2,578 | $0.63 | $1,624.14 | < 1% 7.05M to 7.05M | (41%) |
11-Feb-14 2:55 PM View: | Revance Therapeutics, Inc. (RVNC) | 11-Feb-14 | Conversion | 673,778 | -- | -- | 100% 0 to 673.78K | |
11-Feb-14 2:55 PM View: | Revance Therapeutics, Inc. (RVNC) | 11-Feb-14 | Exercise (in-the money or at-the-money) | 52,236 | -- | -- | 8% 673.78K to 726.01K |